Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria

Barratt, J., Tumlin, J., Suzuki, Y., Kao, A., Aydemir, A., Pudota, K., Jin, H., Gühring, H., & Appel, G. (2022). Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria. Kidney International Reports, 7(8), 1831–1841. https://doi.org/10.1016/j.ekir.2022.05.017
Authors:
Jonathan Barratt
James Tumlin
Yusuke Suzuki
Amy Kao
Aida Aydemir
Kishore Pudota
Hulin Jin
Hans Gühring
Gerald Appel
Affiliated Authors:
Gerald Appel
Subjects:
Pathophysiology of Glomerular Diseases and Nephrotic Syndromes (OpenAlex Topic)
Pathogenesis and Treatment of Pemphigoid Diseases (OpenAlex Topic)
Platelet Disorders and Thrombosis Mechanisms (OpenAlex Topic)
Author Keywords:
april
blys inhibitor
atacicept
galactose-deficient iga1
iga nephropathy
phase ii
proteinuria
april/blys inhibitor
elink
Publication Type:
Article
Unique ID:
10.1016/j.ekir.2022.05.017
PMID:
35967104
DOI:
10.1016/j.ekir.2022.05.017
Journal:
Kidney International Reports
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record
View OpenAlex Record

Record Created: